Exploring the Pharmacological Potential of Carrageenan Disaccharides as Antitumor Agents: An In Silico Approach

Carrageenans have demonstrated enhanced antitumor activity upon depolymerization into disaccharides. However, the pharmacological viability of these disaccharides and their mechanisms of antitumor action remains to be fully elucidated. This study aimed to employ computational tools to investigate th...

Full description

Saved in:
Bibliographic Details
Main Authors: Ohana Leticia Tavares Silva, Monique Gabriela das Chagas Faustino Alves, Hugo Alexandre Oliveira Rocha
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Marine Drugs
Subjects:
Online Access:https://www.mdpi.com/1660-3397/23/1/6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832588051178586112
author Ohana Leticia Tavares Silva
Monique Gabriela das Chagas Faustino Alves
Hugo Alexandre Oliveira Rocha
author_facet Ohana Leticia Tavares Silva
Monique Gabriela das Chagas Faustino Alves
Hugo Alexandre Oliveira Rocha
author_sort Ohana Leticia Tavares Silva
collection DOAJ
description Carrageenans have demonstrated enhanced antitumor activity upon depolymerization into disaccharides. However, the pharmacological viability of these disaccharides and their mechanisms of antitumor action remains to be fully elucidated. This study aimed to employ computational tools to investigate the pharmacological properties and molecular targets pertinent to cancer of the disaccharides derived from the primary carrageenans. Analyses of pharmacological properties predicted by the pkCSM and SwissADME servers indicated that the disaccharides possess a favorable pharmacokinetic profile, although they encounter permeability challenges primarily due to their high polarity and low lipophilicity. Target prediction using SwissTarget and PPB2 identified five carbonic anhydrases, which are also targets of oncology drugs, as common targets for the disaccharides. Molecular docking performed with AutoDock Vina revealed that the binding energies of the disaccharides with carbonic anhydrases were comparable to or greater than those of existing drugs that target these lyases. Notably, six of the complexes formed exhibited interactions between the disaccharides and the zinc cofactor, which represents a primary mechanism of inhibition for these targets. Furthermore, molecular dynamics simulations conducted using GROMACS demonstrated a stable interaction between the disaccharides and carbonic anhydrases. These findings offer new insights into the pharmacological properties and mechanisms of action of carrageenan-derived disaccharides, highlighting their potential for further exploration in clinical trials and experimental studies.
format Article
id doaj-art-3e4c4fabf8634555b960a15afc9d562a
institution Kabale University
issn 1660-3397
language English
publishDate 2024-12-01
publisher MDPI AG
record_format Article
series Marine Drugs
spelling doaj-art-3e4c4fabf8634555b960a15afc9d562a2025-01-24T13:39:26ZengMDPI AGMarine Drugs1660-33972024-12-01231610.3390/md23010006Exploring the Pharmacological Potential of Carrageenan Disaccharides as Antitumor Agents: An In Silico ApproachOhana Leticia Tavares Silva0Monique Gabriela das Chagas Faustino Alves1Hugo Alexandre Oliveira Rocha2Graduate Program in Biochemistry and Molecular Biology, Center of Biosciences, Federal University of Rio Grande do Norte—UFRN, Av. Sen. Salgado Filho, 3000, Natal 59078-900, BrazilGraduate Program in Biochemistry and Molecular Biology, Center of Biosciences, Federal University of Rio Grande do Norte—UFRN, Av. Sen. Salgado Filho, 3000, Natal 59078-900, BrazilGraduate Program in Biochemistry and Molecular Biology, Center of Biosciences, Federal University of Rio Grande do Norte—UFRN, Av. Sen. Salgado Filho, 3000, Natal 59078-900, BrazilCarrageenans have demonstrated enhanced antitumor activity upon depolymerization into disaccharides. However, the pharmacological viability of these disaccharides and their mechanisms of antitumor action remains to be fully elucidated. This study aimed to employ computational tools to investigate the pharmacological properties and molecular targets pertinent to cancer of the disaccharides derived from the primary carrageenans. Analyses of pharmacological properties predicted by the pkCSM and SwissADME servers indicated that the disaccharides possess a favorable pharmacokinetic profile, although they encounter permeability challenges primarily due to their high polarity and low lipophilicity. Target prediction using SwissTarget and PPB2 identified five carbonic anhydrases, which are also targets of oncology drugs, as common targets for the disaccharides. Molecular docking performed with AutoDock Vina revealed that the binding energies of the disaccharides with carbonic anhydrases were comparable to or greater than those of existing drugs that target these lyases. Notably, six of the complexes formed exhibited interactions between the disaccharides and the zinc cofactor, which represents a primary mechanism of inhibition for these targets. Furthermore, molecular dynamics simulations conducted using GROMACS demonstrated a stable interaction between the disaccharides and carbonic anhydrases. These findings offer new insights into the pharmacological properties and mechanisms of action of carrageenan-derived disaccharides, highlighting their potential for further exploration in clinical trials and experimental studies.https://www.mdpi.com/1660-3397/23/1/6sulfated polysaccharidesbioinformaticsred seaweedcancer
spellingShingle Ohana Leticia Tavares Silva
Monique Gabriela das Chagas Faustino Alves
Hugo Alexandre Oliveira Rocha
Exploring the Pharmacological Potential of Carrageenan Disaccharides as Antitumor Agents: An In Silico Approach
Marine Drugs
sulfated polysaccharides
bioinformatics
red seaweed
cancer
title Exploring the Pharmacological Potential of Carrageenan Disaccharides as Antitumor Agents: An In Silico Approach
title_full Exploring the Pharmacological Potential of Carrageenan Disaccharides as Antitumor Agents: An In Silico Approach
title_fullStr Exploring the Pharmacological Potential of Carrageenan Disaccharides as Antitumor Agents: An In Silico Approach
title_full_unstemmed Exploring the Pharmacological Potential of Carrageenan Disaccharides as Antitumor Agents: An In Silico Approach
title_short Exploring the Pharmacological Potential of Carrageenan Disaccharides as Antitumor Agents: An In Silico Approach
title_sort exploring the pharmacological potential of carrageenan disaccharides as antitumor agents an in silico approach
topic sulfated polysaccharides
bioinformatics
red seaweed
cancer
url https://www.mdpi.com/1660-3397/23/1/6
work_keys_str_mv AT ohanaleticiatavaressilva exploringthepharmacologicalpotentialofcarrageenandisaccharidesasantitumoragentsaninsilicoapproach
AT moniquegabrieladaschagasfaustinoalves exploringthepharmacologicalpotentialofcarrageenandisaccharidesasantitumoragentsaninsilicoapproach
AT hugoalexandreoliveirarocha exploringthepharmacologicalpotentialofcarrageenandisaccharidesasantitumoragentsaninsilicoapproach